Webinar: Diabetic PN with Rodica Pop Busui, MD, PhD
Demystifying Diabetic Peripheral Neuropathy with Rodica Pop Busui, MD, PhD
Nerve damage caused by diabetes, a condition called diabetic peripheral neuropathy (DPN), is a common and debilitating complication that most often affects the extremities. Patients with diabetic peripheral neuropathy often develop painful symptoms which is known as painful diabetic peripheral neuropathy or diabetic nerve pain.
Diabetic nerve pain can be an extremely challenging condition to diagnose, treat and manage effectively, and the excruciating pain patients may experience has a significant impact on their quality of life.
This webinar is designed to help patients recognize key symptoms associated with diabetic nerve pain of the feet (achiness, throbbing, burning sensations, etc.) and serve as a foundation to help empower patients to speak with their healthcare providers – fostering more productive conversations around diagnosis, disease management and potential solutions for painful diabetic neuropathy.
The Foundation for Peripheral Neuropathy (FPN) is pleased to welcome Rodica Pop-Busui, MD, PhD, a prominent diabetologist at Michigan Medicine and a recognized leader in the field of diabetes and diabetes complications. Her research interests involve chronic complications of diabetes, particularly diabetic peripheral and cardiovascular autonomic neuropathy, as well as diabetic foot complications, diabetic kidney disease and cardiovascular disease, and the design and conduct of traditional and pragmatic clinical trials for patients with diabetes.
Webinar generously sponsored by Averitas Pharma and held live on Wednesday, September 7, 2022.
From Our Blog...
Underlying Cause of Diabetic Peripheral Neuropathy Targeted in Gene Therapy Trial
VM BioPharma, the United States division of ViroMed Co., Ltd. in Seoul, Korea, announced the first patient was dosed in the recently initiated Phase 3
Small Nerve Fibers Defy Neuropathy Conventions
Peripheral neuropathy research study suggests even prediabetes could cause nerve damage. Peripheral neuropathy research results of a small study of people with tingling pain in
FPN Connects Peripheral Neuropathy Researchers at Astellas Pharma to the Patients They Are Hoping to Serve
On December 3, 2015, Astellas Pharma US, Inc. (the U.S. affiliate of Astellas Pharma Inc.), a R&D-driven global pharmaceutical company, invited the Foundation for Peripheral
New Findings Point to Central Nervous System Role in Painful Diabetic Peripheral Neuropathy
Emerging evidence suggests that the central nervous system (CNS) is a key contributor to the problem of painful peripheral nerve disease in people with diabetes,
Study Reports Peripheral Neuropathy is Associated with Mitochondrial Dysfunction
A new study led by researchers at McGill University in Canada recently revealed that peripheral neuropathy is associated with a mitochondrial dysfunction and a bioenergetic
Stem Cells Show Promise as Treatment for Diabetic Neuropathy
Research released earlier this summer shows that rats who received intra-muscular injections of mesenchymal stem cells (MSC’s are adult stem cells traditionally found in the